Impact of the Microbiota on the Likelihood of Renal Graft Rejection
Recruiting
Observational Study
Kidney Transplant Rejection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Observational
- Participants needed
- 70 (estimated)
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Identification of a bacterial signature in the blood or stool that may be associated with acute rejection in patients treated with Nulojix during their first year of transplant.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients called for a kidney transplant
* Induction therapy with Simulect, maintenance therapy with Nulojix, mycophenolate acid and steroids
* Patient having signed the informed consent
Exclusion Criteria:
* Multiple grafts combined or sequential
* Induction therapy with pol…
Contacts